• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Onconetix, Inc. - Common Stock (NQ:ONCO)

    4.120 +0.300 (+7.85%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 287,317
    Open 3.710
    Bid (Size) 3.990 (3)
    Ask (Size) 4.180 (3)
    Prev. Close 3.820
    Today's Range 3.620 - 4.190
    52wk Range 2.450 - 552.50
    Shares Outstanding 22,171,931
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million. 
    Via Benzinga
    Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
    From Onconetix, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -92.6%
    -92.6%
    1 Month
    +53.7%
    +53.7%
    3 Month
    -16.2%
    -16.2%
    6 Month
    -23.8%
    -23.8%
    1 Year
    -99.0%
    -99.0%

    More News

    Read More
    Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement
    From Onconetix, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
    From Onconetix, Inc.
    Via GlobeNewswire
    Friday's after hours session: top gainers and losers
    Via Chartmill
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Thursday's session: gap up and gap down stocks
    Via Chartmill
    Discover the top movers in Thursday's pre-market session.
    Via Chartmill
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Top movers analysis one hour before the close of the markets on 2025-07-16: top gainers and losers in today's session.
    Via Chartmill
    Dow Surges Over 100 Points; Goldman Sachs Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    US Stocks Mixed; Bank of America Earnings Top Views
    Via Benzinga
    ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    There are notable gap-ups and gap-downs in today's session.
    Via Chartmill
    Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
    From Onconetix, Inc.
    Via GlobeNewswire
    Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
    From Onconetix, Inc.
    Via GlobeNewswire
    Curious about the stocks that are showing activity after the closing bell on Thursday?
    Via Chartmill
    Top movers analysis in the middle of the day on 2025-06-11: top gainers and losers in today's session.
    Via Chartmill
    Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
    From Onconetix, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga

    Frequently Asked Questions

    Is Onconetix, Inc. - Common Stock publicly traded?
    Yes, Onconetix, Inc. - Common Stock is publicly traded.
    What exchange does Onconetix, Inc. - Common Stock trade on?
    Onconetix, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Onconetix, Inc. - Common Stock?
    The ticker symbol for Onconetix, Inc. - Common Stock is ONCO on the Nasdaq Stock Market
    What is the current price of Onconetix, Inc. - Common Stock?
    The current price of Onconetix, Inc. - Common Stock is 4.120
    When was Onconetix, Inc. - Common Stock last traded?
    The last trade of Onconetix, Inc. - Common Stock was at 10/09/25 04:00 PM ET
    What is the market capitalization of Onconetix, Inc. - Common Stock?
    The market capitalization of Onconetix, Inc. - Common Stock is 91.35M
    How many shares of Onconetix, Inc. - Common Stock are outstanding?
    Onconetix, Inc. - Common Stock has 91M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.